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Correction
P Yu-Wai-Man, P G Grifﬁths, G Hudson, et al. Inherited mitochondrial optic neuropathies.
J Med Genet 2009;46:145e58. Errors appeared in the ﬁrst paragraph of the ‘Clinical features’
section in this paper. The correct paragraph should read as follows:
‘The clinical features of DOA (OMIM 165500) were ﬁrst described in one British family by
Batten in 1896
119 120; the phenotype was further clariﬁed by Kjer in his extensive study of
Danish families in the 1950’s,
119 120 distinguishing it from LHON with which the disease was
often confused. The prevalence of DOA is not well established and robust estimates based on
molecular conﬁrmation are not available, although a historical ﬁgure of 1 in 50,000 among
Caucasians is often quoted in the literature.
121 It is thought to be the most common inherited
optic neuropathy in Denmark with a population frequency of 1 in 12,000, and this much
higher prevalence has been linked to a mutational founder event.
122’
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